GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan, Inc. (AGN) [hlAlert]

Rating:
Overweight
AGN
down 6.10 %

Allergan Plc (AGN) upgraded to Overweight with price target $400 by JP Morgan

Posted on: Monday,  Aug 3, 2015  10:25 AM ET by JP Morgan

JP Morgan rated Overweight Allergan Plc (NYSE: AGN) on 08/03/2015, when the stock price was $332.27. Since
then, Allergan Plc has lost 6.10% as of 11/24/2015's recent price of $312.00.
If you would have followed this JP Morgan's recommendation on AGN, you would have lost 6.1% of your investment in 113 days.

Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2008, the Company marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its generic and brand divisions, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its distribution division. The Company?s operations are based predominantly in the United States and India, with its key commercial market being the United States. In July 2008, Watson and Mylan Inc. announced that Mylan Inc. has acquired Watson?s 50% interest in the Somerset Pharmaceuticals, Inc. joint venture. In December 2009, the Company completed the acquisition of Arrow Group.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy